Kevin Young, EVP, Commercial Operations at GILEAD SCIENCES INC (GILD), sold 30,000 shares at $41.49 ($1.2M) on 2007-10-09, disclosed to the SEC on 2007-10-10.
Scheduled sale ($1.2M) by EVP, Commercial Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.43 | 2,000 | $83K | 6.6% |
| 2 | $41.46 | 1,000 | $41K | 3.3% |
| 3 | $41.49 | 500 | $21K | 1.7% |
| 4 | $41.50 | 2,000 | $83K | 6.7% |
| 5 | $41.51 | 500 | $21K | 1.7% |
| 6 | $41.53 | 1,000 |
| $42K |
| 3.3% |
| 7 | $41.55 | 1,000 | $42K | 3.3% |
| 8 | $41.56 | 2,000 | $83K | 6.7% |
| 9 | $41.58 | 3,500 | $146K | 11.7% |
| 10 | $41.59 | 3,000 | $125K | 10.0% |
| 11 | $41.60 | 5,500 | $229K | 18.3% |
| 12 | $41.61 | 1,000 | $42K | 3.3% |
| 13 | $41.62 | 2,000 | $83K | 6.7% |
| 14 | $41.64 | 1,000 | $42K | 3.3% |
| 15 | $41.65 | 1,000 | $42K | 3.3% |
| 16 | $41.65 | 2,500 | $104K | 8.3% |
| 17 | $41.66 | 500 | $21K | 1.7% |
| Total | $41.57 avg | 30,000 | $1.2M | 100% |
| Filing → |
| GILD | SELL | 2013-12-24 | $5.6M | — | Filing → |
| GILD | SELL | 2013-11-25 | $5.6M | — | Filing → |
| GILD | SELL | 2013-10-25 | $5.1M | — | Filing → |